Relationship between serum alkaline phosphatase and pyridoxal-5'-phosphate levels in hypophosphatasia

Clinical Science

Volumn 94, Issue 2, 1998, Pages 203-206

  Iqbal, S J ^a   Brain, A ^b   Reynolds, T M ^c   Penny, M ^b   Holland, S ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

^c DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Alkaline phosphatase; Hypophosphatasia; Pyridoxal 5' phosphate

Indexed keywords

ALKALINE PHOSPHATASE; PHOSPHOETHANOLAMINE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE; PYROPHOSPHATE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FETUS; HETEROZYGOTE; HUMAN; HYPOPHOSPHATASIA; MALE; PRIORITY JOURNAL; SCREENING; SKELETON MALFORMATION; VITAMIN METABOLISM;

EID: 0031972544     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0940203     Document Type: Article

References (20)

1. Harris H. The human alkaline phosphatases; what we know and what we don't know. Clin Chem Acta 1990; 18B: 133-50.
2. Whyte MP. Hypophosphatasia. In: Favins MJ, ed. Primer on metabolic bone diseases and disorders of mineral metabolism. 2nd edn. New York: Raven Press, 1993: 288-90.
3. McCance RA, Morrison AB, Dent CE. The excretion of phosphoethanolamine and hypophosphatasia. Lancet 1955; 1: 131.
4. Russell RG. Excretion of inorganic pyrophosphate in hypophosphatasia. Lancet 1965; 2: 461.
5. Whyte MP, Mahuren JD, Vrabel LA, Coburn SP. Markedly increased circulating pyridoxal-5′-phosphate levels in hypophosphatasia. J Clin Invest 1985; 76: 752-6.
6. Iqbal SJ, Taylor WH, Roberts NB, Darlow JD. Raised serum acid phosphatase activity in an adult with hypophosphatasia. J Inher Metab Dis 1983; 6 (Suppl. 2): 103-4.
7. 6 in human serum. J Liquid Chromatogr 1992; 15: 897-914.
8. 6 vitamins in biological material. Clin Chim Acta 1981; 109: 159-67.
9. 6 compounds in plasma. Clin Chem 1984; 35: 241-5.
10. Reference deleted.
11. 6. Proceedings of the Third International Conference, Gosler-Hahenkle, Germany. New York: Alan R Liss Inc., 1987: 3-28.
12. Mitchell D, Wagner C, Stone WJ, et al. Abnormal regulation of plasma pyridoxal-5′-phosphate in patients with liver disease. Gastroenterology 1976; 71: 1043-9.
13. Anderson BB, O'Brien H, Griffin GE, Mollin DL. Hydrolysis of pyridoxal-5′-phosphate in plasma in conditions with raised alkaline phosphatase. Gut 1980; 21: 192-4.
14. 6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5′-phosphate. J Clin Invest 1988; 81: 1234-9.
15. Mollin DL, Hoffbrand V. Sideroblastic anaemia. In: Dykes SC, ed. Recent advances in clinical pathology. Series V. London: Churchill, 1968: 273.
16. Leevy CM, Valdellon E, Smith F. Nutritional factors in alcoholism and its complications. In: Israel Y, Mardones J, eds. Biological basis of alcoholism. New York: Wiley Interscience, 1971: 365-70.
17. Shaumburg H, Kaplan A, Winderbank N, et al. Sensory neuropathy from pyridoxine abuse; a new megavitamin syndrome. N Engl J Med 1983; 309: 445-8.
18. Henthorn PS, Whyte MP. Missense mutations of tissue non specific alkaline phosphatase gene in hypophosphatasia. Clin Chem 1992; 38/12: 2501-5
19. Macfarlane JD, Poorthius BJ, Kamp JJP, Russell RGG, Caswell AM. Hypophosphatasia: biochemical screening of a Dutch kindred and evidence that urinary excretion of inorganic pyrophosphate is a marker for the disease. Clin Chem 1988; 34: 1937-41.
20. Whyte MP. Alkaline phosphatase: physiological role explored in hypophosphatasia. In: Peck WA, ed. Bone and Mineral Research/6. Amsterdam/ New York/Oxford: Elsevier, 1989: 175-218.